SpaceX shares jumped 7% to $150.84 and Tesla rose 7% to $381.69 on Thursday as investors positioned ahead of the approaching Starship Test 14 flight, a two-name Musk-linked trade that left Rocket Lab up just 1% and the Procure Space ETF flat.
返回
SpaceX jumps 7% as Starship Test 14 nears, Tesla rides along
A pending launch window is concentrating Thursday's buying into two Musk-linked names while the rest of the space sector barely moves. SpaceX shares climbed 7% to $150.84 as investors positioned for the approaching Starship Test 14 flight, and Tesla rose the same amount to $381.69 on autonomy optimism and its equity and manufacturing ties to the rocket maker.
The bid was narrow rather than broad. Rocket Lab ticked up just 1% to $63.66, the Procure Space ETF gained 0.2% to $43.23, and the SPDR S&P 500 ETF rose 1% to $772.46 — a combination that confirms the move is an ecosystem trade, not rotation into space names.
SpaceX said Starship Test 14, the next flight of its fully reusable rocket standing about 400 feet tall as the largest ever built, could be days away, though no launch date has been confirmed. The event sits in an approaching window rather than a scheduled one, leaving binary event risk on top of the day's enthusiasm. SpaceX has run hard into the pending test, up 23% over the past month through the prior close, backed by Q2 2026 revenue of $7.81 billion versus the $6.82 billion estimate and a $47.5 billion backlog.
Terafab ties the two names together
The capital commitments stack up behind the launch window. SpaceX confirmed on Aug. 6 the Grimes County, Texas site for Terafab, a semiconductor project jointly backed with Tesla carrying an initial commitment of $16.8 billion and at least 3,000 employees. ARK Invest estimated Terafab could eventually require $1 trillion in total investment, surpassing the inflation-adjusted $704 billion cost of the U.S. Interstate Highway System. SpaceX also disclosed plans to invest $100 billion in Starbase, Louisiana, with construction starting in 2027 and a first launch targeted as early as 2029.
Tesla tells a different tape within the same story. The stock was down 21% year to date and up 11% over the past month through the prior close, so the ecosystem narrative is being priced differently across the two names. Tesla's Q2 delivered record deliveries of 480,126 vehicles and nearly 1.5 million paid FSD customers globally, though operating margin compressed to 1.4%. Tesla holds a $2 billion SpaceX equity stake, and Starlink is being integrated into Cybercab and other Tesla vehicles.
Rocket Lab is the outlier. The stock was down 10% year to date through the prior close and is not participating Thursday despite record Q2 revenue of $234.07 million and a $2.36 billion backlog, up 137% year over year. The Neutron medium-lift rocket targets Q4 2026 delivery to the launch pad, but the narrow enthusiasm shows buyers are focused on Musk-linked catalysts rather than launch beta.
SpaceX's Q2 print supports the ambition. AI segment revenue reached $2.56 billion, up 247% year over year, and Starlink subscribers doubled to 12 million. On Polymarket, prediction markets assign a 0.9 probability that SPCX finishes Thursday higher, a bullish tilt that has already priced in much of the good news.
The bear case is worth weighing. Tesla's Q2 non-GAAP EPS came in at $0.33 versus the $0.54 estimate, a real miss, and free cash flow turned negative at negative $1.09 billion. If Starship Test 14 disappoints, both names could give back the same-day gains quickly. Investors sizing positions across the two names may want to keep space-ecosystem exposure moderate given the binary launch risk sitting on top of already large capital plans.
This article is for informational purposes only and does not constitute investment advice.
